February 2022 Drug Launch Roundup
Highlights from drug launches in February 2022 – including controversy around Ruzurgi, and new orphan drugs.
Highlights from drug launches in February 2022 – including controversy around Ruzurgi, and new orphan drugs.
A summary of the highlights in new drug approvals that happened in January 2022, including new JAKs and therapies for cancer, endocrine disorders and eczema.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings